BMS builds US plant

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb plans a $2.3 billion drug manufacturing facility in Houston to produce small-molecule and biologic medicines, creating nearly 500 skilled jobs as part of a broader U.S. investment